Juan-Manuel Sancho

34PUBLICATIONS
132CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 06, 2026
Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.

|Jun 26, 2026
Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. Cancers 2026, 18, 395.

|Feb 13, 2026
Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2025.

Francisco-Javier Peñalver, Laura Magnano, Sara Alonso-Álvarez

|May 01, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.

Michael Wang, David Salek, David Belada

|Apr 09, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

Miriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro

|Jan 08, 2025
Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real-World Data.

Minna Harmanen, Mika Hujo, Reijo Sund

Pageof 6

Frequent Collaborators

6 joint publications

Armando López-Guillermo

4 joint publications

Raúl Córdoba

4 joint publications

Santiago Mercadal

4 joint publications

Mariana Beatriz Bastos Oreiro